Description
Bromocriptine Mesylate Tablets
Healthy Inc is a specialized global supplier and exporter of potent ergot-derived dopamine agonists. We provide high-purity Bromocriptine Mesylate Tablets, sourced from WHO–GMP certified solid dosage facilities. This “Prolactin Inhibitor” is a top export to endocrinology clinics, fertility centers, and neurology departments in Africa, LATAM, and Southeast Asia, serving as the primary therapy for hyperprolactinemia-induced infertility and an essential adjunct in Parkinson’s Disease management.
Product Overview
This formulation contains Bromocriptine Mesylate, a semi-synthetic ergot alkaloid derivative.
The “Hormone Regulator” Specialist:
- Mechanism (Endocrinology): Bromocriptine mimics the action of dopamine (Prolactin Inhibiting Factor) on the Anterior Pituitary Gland. It strongly activates D2 receptors, signaling the gland to stop secreting Prolactin. This restores normal ovulation in women and testosterone levels in men suppressed by high prolactin.
- Mechanism (Neurology): In Parkinson’s Disease, it directly stimulates dopamine receptors in the Corpus Striatum of the brain, compensating for the lost dopamine-producing neurons and improving motor function.
- Acromegaly: It paradoxically lowers growth hormone (GH) levels in patients with pituitary tumors (Acromegaly).
Product Composition & Strength
We supply this product as Tablets (scored). The 2.5 mg strength is the universal standard, often scored to allow for 1.25 mg starting doses to minimize nausea.
| Active Ingredient | Strength (Standard) | Primary Role | |
|---|---|---|---|
| Bromocriptine Mesylate USP/BP | 1.25 mg | Initiation Dose (Pediatric/Sensitive) | |
| Bromocriptine Mesylate USP/BP | 2.5 mg | Standard Therapeutic Dose | |
| Excipients | Q.S. | Lactose / Maleic Acid / Silica | Stabilizer / Filler |
*Pack Sizes: Blister packs of 10s (Box of 10×10), 30s (Glass Bottle or Blister), or Bulk HDPE Jars.
Technical & Logistics Specifications
Critical data for Pharmaceutical Importers and Distributors.
| HS Code | 3004.90.99 (Other Medicaments) |
| CAS Number | 25614-03-3 |
| Dosage Form | Tablet (Oral) |
| Packaging | Alu-Alu Blister or Amber Glass (Light Sensitive) |
| Storage | Store below 25°C. Protect from Light. |
| Certificates | WHO-GMP, COPP, Free Sale Certificate |
Manufacturing Authority
Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.
- Light Stability: Ergot alkaloids are notoriously unstable and turn brown upon exposure to light. We manufacture in amber-light suites and utilize high-barrier packaging to ensure the product remains potent (white) until the expiration date.
- Dissolution Profile: Formulated for rapid disintegration to ensure quick absorption, although food is recommended to buffer the gastric lining.
Therapeutic Indications (Human Use)
Indicated for the treatment of pituitary and neurological disorders:
- Hyperprolactinemia: Treatment of galactorrhea (spontaneous milk flow), amenorrhea (lack of periods), and infertility in both men and women caused by high prolactin.
- Prolactinomas: Shrinking of prolactin-secreting pituitary adenomas (tumors).
- Parkinson’s Disease: Adjunctive treatment to Levodopa (reduces “off” time and dyskinesia).
- Acromegaly: Adjunct therapy to reduce Growth Hormone levels.
- Type 2 Diabetes: (Specific quick-release formulations) To improve glycemic control.
Dosage & Administration
Recommended Dosage (Strictly as per Endocrinologist):
- Route: Oral.
- Hyperprolactinemia: Start with 1.25 mg (half tablet) at bedtime with a snack. Gradually increase to 2.5 mg twice or 3 times daily.
- Parkinson’s Disease: Start low (1.25 mg twice daily) and titrate slowly every 2–4 weeks. Maintenance range is often 10–30 mg daily.
- Administration (CRITICAL):
- ALWAYS take with food. Taking on an empty stomach frequently causes severe nausea, vomiting, and dizziness.
Safety Warnings:
- Hypotension (First-Dose Phenomenon): Can cause a sudden drop in blood pressure and fainting, especially upon standing. The first dose should be taken while lying down at bedtime.
- Fibrosis: Long-term high-dose use (in Parkinson’s) has been associated with pleural or retroperitoneal fibrosis. Monitor lung function.
- Postpartum Stroke Risk: Use for routine suppression of lactation (drying up milk) is no longer recommended in some countries due to rare risks of stroke/seizures in women with high blood pressure.
Global Export & Contract Manufacturing Services
Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Bulk Drug Distributors. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for OSD (Oral Solid Dosage) forms, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Hospital Tender Supplier for government procurement in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Generic Medicine Wholesaler receives WHO-GMP certified products at competitive rates.
Commercial Inquiries
For hospital tenders, bulk export, or distributor pricing, please contact our export team.
WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in
